FDA Grants RMAT Designation To Cellerant’s “Off-The-Shelf” Romyelocel-L Cell Therapy

Cellerant Therapeutics Inc., is a clinical-stage company developing innovative cell and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant’s romyelocel-L (human myeloid progenitor cells) “off-the-shelf” cell therapy does not require HLA matching and is designed to prevent...

The Dalglish Family 22q Clinic And Biobank

The Dalglish Family 22q Clinic is the world's first multidisciplinary clinic devoted to adults with 22q11.2 deletion syndrome (22q11.2DS) and their families, located at Toronto General Hospital, Canada. The founding of the clinic was made possible thanks to a...
The Brainstorm Consortium has analyzed data from over 1 million people.

Biobanking Science: Brainstorm Consortium Finds Genetic Link for Brain Diseases

One of the major benefits of biobanking is the ability to safely collect and store large numbers of biological samples. This allows researchers to generate large datasets to study the genetic cause of various diseases. The Brainstorm Consortium uses...

Bruker B.I.BioBankTool™ For Biobank Standardization And Quality Control

Bruker Corporation is a manufacturer of analytical and medical instruments, for use in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and...

IPS HEART Aims To Use Induced Pluripotent Stem Cells To Treat Heart Attack

IPS HEART is a privately-held biopharmaceutical company, founded in 2014, dedicated to addressing heart attack, heart failure and Duchenne cardiomyopathy via next generation cellular therapy. IPS HEART was the first company to exclusively focus on induced pluripotent stem cells...

In-Home Clinical Services Enhanced By LabConnect And Symphony Clinical Research Partnership

LabConnect, LLC, was founded in 2002, providing a global central laboratory, biorepository and client-inspired support services which include routine specialized laboratory testing, kit building, sample management, and data management, serving biopharmaceutical, medical device, and Contract Research Organisation (CRO) clients....

Emulate Inc.’s Organs-On-Chips Technology Secures $36 Million Financing

Emulate Inc., has secured a $36 million Series C financing round led by Founders Fund. With the financing transaction, Aaron VanDevender, Chief Scientist and Principal at Founders Fund, joins Emulate’s board of directors. Founders Fund is a leading Bay Area...

AcuraStem Has Secured A $3.7 Million SBIR Fast-Track Grant To Leverage Patient Stem Cells

Founded in 2016, the company AcuraStem is led by an exceptional team of PhDs, professors, technology entrepreneurs, and successful drug company veterans utilizing the latest scientific breakthroughs to first address one of the most challenging, but tractable diseases, amyotrophic...
Measure cell-free tumor DNA quality using Qubit and NanoDrop.

Biobanking Science: Measuring Cell-Free Tumor DNA

Circulating cell-free tumor DNA (cfDNA) is released by solid tumors into the blood stream. There is a lot of interest among the medical and biobanking communities in using cfDNA as a relatively non-invasive way of predicting cancer prognosis and...

$99 Shotgun Microbiome Sequencing And Strain Characterization – CoreBiome Services

Focused on accelerating discovery, CoreBiome is a microbiome genomics company unleashing the translational potential of the microbiome. Core customers are in the pharmaceutical, agriculture, and research communities. Fast and information-rich characterizations of microbial diversity and function are provided by...